Relay Therapeutics, Inc. (RLAY)
12.78
+0.68
(+5.62%)
USD |
NASDAQ |
May 19, 13:49
Relay Therapeutics Shareholders Equity (Quarterly) : 642.18M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 387.58M |
| Spyre Therapeutics, Inc. | 670.81M |
| Revolution Medicines, Inc. | 1.500B |
| Tango Therapeutics, Inc. | 391.51M |
| Summit Therapeutics, Inc. | 545.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 699.61M |
| Total Liabilities (Quarterly) | 57.43M |
| Debt to Equity Ratio | 0.0492 |
| Current Ratio | 22.13 |
| Net Debt Paydown Yield | 0.18% |